BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2806 related articles for article (PubMed ID: 7902020)

  • 1. Immunohistochemical study of Spitz nevi and malignant melanoma with use of antibody to proliferating cell nuclear antigen.
    Niemann TH; Argenyi ZB
    Am J Dermatopathol; 1993 Oct; 15(5):441-5. PubMed ID: 7902020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of proliferating cell nuclear antigen in Spitz nevus.
    Penneys N; Seigfried E; Nahass G; Vogler C
    J Am Acad Dermatol; 1995 Jun; 32(6):964-7. PubMed ID: 7751466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.
    Nagasaka T; Lai R; Medeiros LJ; Brynes RK; McCourty A; Harada T; Saddik M
    Am J Dermatopathol; 1999 Apr; 21(2):115-20. PubMed ID: 10218669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pattern of HMB-45 antibody staining in compound Spitz nevi.
    Bergman R; Dromi R; Trau H; Cohen I; Lichtig C
    Am J Dermatopathol; 1995 Dec; 17(6):542-6. PubMed ID: 8599465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody.
    Takahashi H; Strutton GM; Parsons PG
    Histopathology; 1991 Mar; 18(3):221-7. PubMed ID: 1675189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis.
    Kapur P; Selim MA; Roy LC; Yegappan M; Weinberg AG; Hoang MP
    Mod Pathol; 2005 Feb; 18(2):197-204. PubMed ID: 15467715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of p53 protein expression in Spitz nevus as compared with other melanocytic lesions.
    Bergman R; Shemer A; Levy R; Friedman-Birnbaum R; Trau H; Lichtig C
    Am J Dermatopathol; 1995 Dec; 17(6):547-50. PubMed ID: 8599466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.
    McNutt NS; Urmacher C; Hakimian J; Hoss DM; Lugo J
    J Cutan Pathol; 1995 Dec; 22(6):502-17. PubMed ID: 8835170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative activity of primary cutaneous melanocytic tumours.
    Kuwata T; Kitagawa M; Kasuga T
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases.
    Harvell JD; Bastian BC; LeBoit PE
    Am J Surg Pathol; 2002 May; 26(5):654-61. PubMed ID: 11979096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-fos protein expression in Spitz nevi, common melanocytic nevi, and malignant melanomas.
    Bergman R; Kerner H; Manov L; Friedman-Birnbaum R
    Am J Dermatopathol; 1998 Jun; 20(3):262-5. PubMed ID: 9650699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas.
    Kanter-Lewensohn L; Hedblad MA; Wejde J; Larsson O
    Mod Pathol; 1997 Sep; 10(9):917-20. PubMed ID: 9310955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
    Isabel Zhu Y; Fitzpatrick JE
    J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative activities in Spitz nevus compared with melanocytic nevus and malignant melanoma using expression of PCNA/cyclin and mitotic rate.
    Tu P; Miyauchi S; Miki Y
    Am J Dermatopathol; 1993 Aug; 15(4):311-4. PubMed ID: 8105711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
    Fullen DR; Zhu W; Thomas D; Su LD
    J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate DNA cytometry discriminates between Spitz nevi and malignant melanomas because large polymorphic nuclei in Spitz nevi are not aneuploid.
    Vogt T; Stolz W; Glässl A; Abmayr W; Hohenleutner U; Schmoeckel C; Schiffner R; Landthaler M
    Am J Dermatopathol; 1996 Apr; 18(2):142-50. PubMed ID: 8739988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative activity in Spitz's naevi compared with other melanocytic skin lesions.
    Hofmann-Wellenhof R; Rieger E; Smolle J; Kerl H
    Melanoma Res; 1993 Oct; 3(5):313-7. PubMed ID: 7904841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 141.